Chile has built a national pipeline for turning university research into licensable intellectual property, pairing CORFO-funded technology transfer hubs with the patent office INAPI — and the model deserves a hard look from R&D managers who license from, or partner with, Latin American institutions.

The framework, profiled by CASRAI, rests on two institutions doing complementary jobs. CORFO, Chile's economic development agency, funds technology transfer hubs that sit between universities and industry. INAPI, the national industrial property institute, handles the patenting machinery underneath. Together they form what CASRAI presents as a replicable IP-commercialisation model for university research systems.

What do the CORFO hubs actually do?

Technology transfer offices are expensive. Most Latin American universities historically lacked them, which meant inventions stalled at the lab bench — no disclosure process, no patent strategy, no industry contact. CORFO's hubs address that gap by centralising the commercialisation function rather than forcing every institution to build its own office from scratch.

For R&D managers outside Chile, that centralisation matters in practical terms. It changes who you negotiate with. Instead of approaching a single university's office — if one exists — you deal with a hub that aggregates IP from multiple institutions. That should mean clearer licensing counterparts and, in theory, a denser portfolio of available technologies in any given field.

Where does INAPI fit in?

INAPI anchors the patent side. A national IP office gives university inventions a formal route to protection, which is the precondition for any licensing deal worth doing. Without patents filed through a credible office, university technology is hard to license on exclusive terms — and exclusivity is usually what industry partners want before they invest in development.

The CASRAI profile positions the CORFO–INAPI pairing as a model, implying other national research systems could copy it. That claim needs interrogation. Chile benefits from institutional scale and government commitment that not every comparable economy can muster. The profile does not publish licensing revenue figures, deal counts or survival rates for spinouts, so the model's commercial track record remains an open question.

What should R&D managers watch?

For portfolio and partnership decisions, three things follow from the Chilean setup:

• Licensing negotiations with Chilean university IP should route through CORFO-supported hubs rather than ad hoc institutional contacts.
• INAPI-issued patents provide the formal protection layer, but due diligence on scope and enforcement history remains the acquirer's job.
• The model's stated replicability means similar hub structures may appear in neighbouring research systems, creating new sourcing geographies for university-derived technology.

How strong is the evidence?

Candidly, the source profile is a framework description, not an outcome evaluation. CASRAI names the institutions and the structural logic but does not attach measured results — no disclosed licensing income, no count of patents filed through the hubs, no spinout formation data. Anyone weighing the model against, say, the US Bayh-Dole system or the UK's knowledge exchange frameworks should treat it as institutional design first and performance claim second.

What the profile does establish is that Chile has committed public infrastructure to university IP commercialisation, with named national agencies in defined roles. That commitment alone shifts the risk calculus for cross-border research collaborations. Where a functioning transfer hub and patent office exist, industry partners face fewer orphaned inventions and fewer ownership disputes.

The next signal to watch is quantitative: whether CORFO and INAPI publish deal-level and revenue data that lets outsiders judge whether the model transfers technology at meaningful scale, or simply reorganises it.